News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
September 2, 2025
·
10 min read
Press Releases
Aires Announces Record Q2 2025 Revenue of $6.0 Million & 115% YoY Sales Growth
September 2, 2025
·
12 min read
Press Releases
Soricimed Biopharma Inc. Strengthens Executive Team with Appointment of Dr. Michael Groaning PhD, as Chief Scientific Officer
September 2, 2025
·
3 min read
Press Releases
OS Therapies Completes Exercise Inducement and Exchange Offer for All Remaining Outstanding Warrants Issued in Connection with December 2024 Financing
September 2, 2025
·
5 min read
Press Releases
OS Therapies Provides OST-HER2 Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma Program Update Following FDA End of Phase 2 Meeting
September 2, 2025
·
9 min read
Press Releases
BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET
September 2, 2025
·
3 min read
Press Releases
Sharp Therapeutics Corp. Reports Second Quarter 2025 Results and Expands Market Presence with Listing On OTCQB
August 29, 2025
·
4 min read
Press Releases
Theralase(R) Extends Warrants
August 29, 2025
·
3 min read
Press Releases
MustGrow Closes Non-Brokered LIFE Offering of Approximately $2.1 Million, Repricing of Warrants, and Shares for Debt Settlement
August 29, 2025
·
8 min read
Press Releases
PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting and Director Resignation
August 28, 2025
·
5 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us